Malignant Non-Urothelial Neoplasms of the Urinary Bladder: A Review

European Urology

Volumn 44, Issue 6, 2003, Pages 672-681

  Dahm, Philipp ^a   Gschwend, Jürgen E ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Bladder tumors; Non urothelial

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ANTINEOPLASTIC AGENT; BCG VACCINE; CARBOPLATIN; CARCINOGEN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; NITROSAMINE; PACLITAXEL;

ADENOCARCINOMA; BLADDER TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CARCINOSARCOMA; CIGARETTE SMOKING; CYSTECTOMY; HUMAN; INDWELLING CATHETER; LYMPHOMA; MELANOMA; MULTIMODALITY CANCER THERAPY; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PSEUDOTUMOR; RACE DIFFERENCE; REVIEW; RISK FACTOR; SARCOMA; SCHISTOSOMIASIS; SEX DIFFERENCE; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TUMOR CLASSIFICATION; URINARY TRACT INFECTION;

EID: 0348110300     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(03)00416-0     Document Type: Review

References (61)

1. Mostofi FK, Sobin HL, Torlini H. Histological typing of urinary bladder tumors. Geneva: WHO; 1973.
2. Serretta V. Pomara G, Piazza F, Gange E. Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases. Eur Urol 2000;37(1):85-9.
3. Grignon DJ. Neoplasms of the urinary bladder. In: Bostwick DG, Eble JN, editors. Urologic surgical pathology. St. Louis (MO): Mosby-Year Book, Inc; 1997. p. 216-305.
4. El-Sheikh SS, Madaan S, Alhasso A, Abel P, Stamp G, Lalani EN. Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer. BJU Int 2001;88(9):921-7.
5. Gschwend JE, Dahm P, Fair WR. Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 2002;41(4):440-8.
6. Locke JR, Hill DE, Walzer Y. Incidence of squamous cell carcinoma in patients with long-term catheter drainage. J Urol 1985;133(6):1034-5.
7. Bejany DE, Lockhart JL, Rhamy RK. Malignant vesical tumors following spinal cord injury. J Urol 1987;138(6):1390-2.
8. Kaufman JM, Fam B, Jacobs SC, Gabilondo F, Yalla S, Kane JP, et al. Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 1977;118(6):967-71.
9. Navon JD, Soliman H, Khonsari F, Ahlering T. Screening cystoscopy and survival of spinal cord injured patients with squamous cell cancer of the bladder. J Urol 1997:157(6):2109-11.
10. West DA, Cummings JM, Longo WE, Virgo KS, Johnson FE, Parra RO. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology 1999;53(2):292-7.
11. Pannek J. Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy? Urology 2002;59(2):240-4.
12. Stonehill WH, Goldman HB, Dmochowski RR. The use of urine cytology for diagnosing bladder cancer in spinal cord injured patients. J Urol 1997;157(6):2112-4.
13. Richie JP, Waisman J, Skinner DG, Dretler SP. Squamous carcinoma of the bladder: treatment by radical cystectomy. J Urol 1976;115(6):670-2.
14. Swanson DA, Liles A, Zagars GK. Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. J Urol 1990;143(1):37-40.
15. Hussain M, Vaishampayan U, Du W, Redman B, Smith DC. Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer. J Clin Oncol 2001;19(9):2527-33.
16. Ghoneim MA, el-Mekresh MM, el-Baz MA, el-Attar IA, Ashamallah A. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol 1997;158(2):393-9.
17. Fadl-Elmula I, Kytola S, Leithy ME, Abdel-Hameed M, Mandahl N, Elagib A, et al. Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization. BMC Cancer 2002;2(1):5.
18. Muscheck M, Abol-Enein H, Chew K, Moore 2nd D, Bhargava V, Ghoneim MA, et al. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization. Carcinogenesis 2000;21(9):1721-6.
19. Wilson TG, Pritchett TR, Lieskovsky G, Warner NE, Skinner DG. Primary adenocarcinoma of bladder. Urology 1991;38(3):223-6.
20. el-Mekresh MM, el-Baz MA, Abol-Enein H, Ghoneim MA. Primary adenocarcinoma of the urinary bladder: a report of 185 cases. Br J Urol 1998;82(2):206-12.
21. Smeulders N, Woodhouse CR. Neoplasia in adult exstrophy patients. BJU Int 2001;87(7):623-8.
22. Grignon DJ, Ro JY, Ayala AG, Johnson DE, Ordonez NG. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer 1991;67(8):2165-72.
23. Anderstrom C, Johansson SL, von Schultz L. Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study. Cancer 1983;52(7):1273-80.
24. Corica FA, Husmann DA, Churchill BM, Young RH, Pacelli A, Lopez-Beltran A, et al. Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up. Urology 1997;50(3):427-31.
25. Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE. Malignant urachal lesions. J Urol 1984;131(1):1-8.
26. Burnett AL, Epstein JI, Marshall FF. Adenocarcinoma of urinary bladder: classification and management. Urology 1991;37(4):315-21.
27. Henly DR, Farrow GM, Zincke H. Urachal cancer: role of conservative surgery. Urology 1993;42(6):635-9.
28. Siefker-Radtke AO, Gee J, Shen Y, Wen S, Daliani D, Millikan RE, et al. Multimodality management of urachal carcinoma: the M.D. Anderson Cancer Center experience. J Urol 2003;169(4):1295-8.
29. Nakanishi K, Kawai T, Suzuki M, Torikata C. Prognostic factors in urachal adenocarcinoma. A study in 41 specimens of DNA status, proliferating cell-nuclear antigen immunostaining, and argyrophilic nucleolar-organizer region counts. Hum Pathol 1996;27(3):240-7.
30. Fiter L, Gimeno F, Martin L, Gomez Tejeda L. Signet-ring cell adenocarcinoma of bladder. Urology 1993;41(1):30-3.
31. Holmang S, Borghede G, Johansson SL. Primary signet ring cell carcinoma of the bladder: a report on 10 cases. Scand J Urol Nephrol 1997;31(2):145-8.
32. Blute ML, Engen DE, Travis WD, Kvols LK. Primary signet ring cell adenocarcinoma of the bladder. J Urol 1989;141(1):17-21.
33. Choi H, Lamb S, Pintar K, Jacobs SC. Primary signet-ring cell carcinoma of the urinary bladder. Cancer 1984;53(9):1985-90.
34. Walther PJ. Adjuvant/neoadjuvant etoposide/cisplatin and cystectomy for management of invasive small cell carcinoma. J Urol 2002;167(4):285 [Abstract 1124].
35. Trias I, Algaba F, Condom E, Espanol I, Segui J, Orsola I, et al. Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. Eur Urol 2001;39(1):85-90.
36. Blomjous CE, Vos W, De Voogt HJ, Van der Valk P, Meijer CJ. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer 1989;64(6):1347-57.
37. Helpap B. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract. Cancer 2002;95(7):1415-20.
38. Parekh DJ, Jung C, O'Conner J, Dutta S, Smith Jr ER. Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas. Urology 2002;60(1):164.
39. Helpap B. Nonepithelial neoplasms of the urinary bladder. Virchows Arch 2001;439(4):497-503.
40. Russo P, Brady MS, Conlon K, Hajdu SI, Fair WR, Herr HW, et al. Adult urological sarcoma. J Urol 1992;147(4):1032-6 [Discussion 1036-71.
41. Lopez-Beltran A, Pacelli A, Rothenberg HJ, Wollan PC, Zincke H, Blute ML, et al. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. J Urol 1998;159(5):1497-503.
42. Froehner M, Gaertner HJ, Manseck A, Wirth MP. Durable complete remission of metastatic sarcomatoid carcinoma of the bladder with cisplatin and gemcitabine in an 80-year-old man. Urology 2001;58(5):799.
43. Whalen RK, Althausen AF, Daniels GH. Extra-adrenal pheochromocytoma. J Urol 1992;147(1):1-10.
44. Hwang JJ, Uchio EM, Patel SV, Linehan WM, Walther MM, Pacak K. Diagnostic localization of malignant bladder pheochromocytoma using 6-18F fluorodopamine positron emission tomography. J Urol 2003;169(1):274-5.
45. Klingler HC, Klingler PJ, Martin Jr JK, Smallridge RC, Smith SL, Hinder RA. Pheochromocytoma. Urology 2001;57(6):1025-32.
46. Spahn M, Portillo FJ, Grobholz R, Junemann KP, Alken P. Fibromyxoid pseudosarcoma of the urinary bladder. Case report and review of the literature of a rare disease. Urologe A 2001;40(4):315-8.
47. Iczkowski KA, Shanks JH, Gadaleanu V, Cheng L, Jones EC, Neumann R, et al. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms. Mod Pathol 2001;14(10):1043-51.
48. Jones EC, Clement PB, Young RH. Inflammatory pseudotumor of the urinary bladder. A clinicopathological, immunohistochemical, ultrastructural, and flow cytometric study of 13 cases. Am J Surg Pathol 1993;17(3):264-74.
49. Tainio HM, Kylmala TM, Haapasalo HK. Primary malignant melanoma of the urinary bladder associated with widespread metastases. Scand J Urol Nephrol 1999;33(6):406-7.
50. Ainsworth AM, Clark WH, Mastrangelo M, Conger KB. Primary malignant melanoma of the urinary bladder. Cancer 1976;37(4):1928-36.
51. De Torres I, Fortuno MA, Raventos A, Tarragona J, Banus JM, Vidal MT. Primary malignant melanoma of the bladder: immunohistochemical study of a new case and review of the literature. J Urol 1995;154(2 Pt 1):525-7.
52. Ito K, Matsuo Y, Takahashi O, Yajima H, Yamanaka H, Ito H. Synchronous malignant melanoma of the male bulbar urethra and transitional cell carcinoma of the bladder. BJU Int 1999;84(7):877-8.
53. Al-Maghrabi J, Kamel-Reid S, Jewett M, Gospodarowicz M, Wells W, Banerjee D. Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type arising in the urinary bladder: report of 4 cases with molecular genetic analysis. Arch Pathol Lab Med 2001;125(3):332-6.
54. Kempton CL, Kurtin PJ, Inwards DJ, Wollan P, Bostwick DG. Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma. Am J Surg Pathol 1997;21(11):1324-33.
55. Porter MP, Voigt LF, Penson DF, Weiss NS. Racial variation in the incidence of squamous cell carcinoma of the bladder in the United States. J Urol 2002;168(5):1960-3.
56. Montague DK, Boltuch RL. Primary neoplasms in vesical diverticula: report of 10 cases. J Urol 1976;116(1):41-2.
57. Kantor AF, Hartge P, Hoover RN, Fraumeni Jr JF. Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Cancer Res 1988;48(13):3853-5.
58. Wall RL, Clausen KP. Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med 1975;293(6):271-3.
59. Brenner DW, Yore LM, Schellhammer PF. Squamous cell carcinoma of bladder after successful intravesical therapy with Bacillus Calmette-Guerin. Urology 1989;34(2):93-5.
60. Lynch CF, Cohen MB. Urinary system. Cancer 1995;75(Suppl 1):316-29.
61. Kramer SA, Bredael J, Croker BP, Paulson DF, Glenn JF. Primary non-urachal adenocarcinoma of the bladder. J Urol 1979;121(3):278-81.